Free Trial

Pharming Group (OTCMKTS:PHGUF) Hits New 52-Week High - Still a Buy?

Pharming Group logo with Medical background

Pharming Group (OTCMKTS:PHGUF - Get Free Report) reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $1.19 and last traded at $1.19, with a volume of 1000 shares traded. The stock had previously closed at $1.00.

Pharming Group Stock Up 18.5%

The firm's 50-day simple moving average is $0.93 and its 200-day simple moving average is $0.90. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.76 and a current ratio of 3.53. The company has a market capitalization of $795.22 million, a price-to-earnings ratio of -59.25 and a beta of 0.51.

About Pharming Group

(Get Free Report)

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Pharming Group Right Now?

Before you consider Pharming Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharming Group wasn't on the list.

While Pharming Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines